期刊文献+

循证决策就是个体化的临床决策 被引量:4

Evidence-Based Decision-Making is Individualized Clinical Decision-Making
下载PDF
导出
摘要 1 批评家认为循证医学忽视了临床的个体化特点 对循证医学(EBM)持批评态度的人坚持认为EBM忽视了个体患者的多样性,这就是说EBM暗示医生可盲目地使用研究结果,尤其是用于个体患者,而无视其个体差异。 1 Critics say evidence-based medicine doesn't consider the individual Critics of evidence-based medicine (EBM) contend that EBM fails to take into account the diversity of individual patients. In this characterization, EBM would suggest that one blindly apply the results of research studies, and particularly, to individual patients irrespective of their differentiating characteristics.
出处 《中国循证医学杂志》 CSCD 2007年第2期85-98,共14页 Chinese Journal of Evidence-based Medicine
  • 相关文献

参考文献54

  • 1[1]Watanabe CT,Maynard C,Ritchie JL.Comparison of short-term outcomes following coronary artery stenting in men versus women.Am J Cardiol,2001,88(8):848-852
  • 2[2]Lansky AJ,Pietras C,Costa RA,et al.Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction:results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.Circulation,2005,111(13):1611-1618.
  • 3[3]Adu FD,Akinwolere OA,Tomori O,et al.Low seroconversion rates to measles vaccine among children in Nigeria.Bull World Health Organ,1992,70(4):457-460.
  • 4[4]Leontiadis GI,Sharma VK,Howden CW.Systematic review and meta-analysis:enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia-a post hoc analysis from the Cochrane Collaboration.Aliment Pharmacol Ther,2005,21(9):1055-1061.
  • 5[5]Villari P,Manzoli L,Boccia A.Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults:a meta-analysis.Vaccine,2004,22(25-26):3475-3486.
  • 6[6]Trock B J,Leonessa F,Clarke R.Multidrug resistance in breast cancer:a meta-analysis of MDRI/gp 170 expression and its possible functional significance.J Natl Cancer Inst,1997,89(13):917-931.
  • 7[7]Yusuf S,Hawken S,Ounpuu S,et al.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study):case-control study.Lancet,2004,364(9438):937-952.
  • 8[8]Barnett HJ,Eliasziw M,Meldrum HE,et al.Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology,1996,46(3):603-608.
  • 9[9]Tu JV,Hannan EL,Anderson GM,et al.The fall and rise of carotid endarterectomy in the United States and Canada.N Engl J Med,1998,339(20):1441-1447.
  • 10[10]Gersh,B.O.,LH.,Antithrombotic agents:platelet inhibitors,anticoagulants and fibrinolytics.3rd ed.Drugs for the Heart,ed.e.In:Opie LH.1991,Philadelphia:WB Saunders Co.

同被引文献46

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部